Publications by authors named "Wouter Kok"

Claim this Profile
C
Comparing Iliac Artery Sizes to Explain Post-EVAR Non-Obstructive Thrombosis. Comment on Lee et al. Influence of Aortoiliac Geometry on Non-Occlusive Thrombotic Risk Following Endovascular Repair of Abdominal Aortic Aneurysms. 2025, , 2134.
Wouter Kok

Diagnostics (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring patients with transthyretin amyloid cardiomyopathy.
Wouter E Kok

Heart· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures Measured by Invasive Hemodynamic Monitoring.
Mylène Barry-Loncq DE Jong, Youssra Allach, Sabrina Abou Kamar, Pascal R D Clephas, Hans-Peter Brunner-LA Rocca, Wouter E M Kok

J Card Fail· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors: A DCCSS-LATER study.
Bente M Houtman, Iris Walraven, Livia Kapusta, Arco J Teske, Eline van Dulmen-den Broeder, Wouter E M Kok

Pediatr Blood Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital consults in heart failure care: a randomized controlled trial.
Jelle P Man, Maarten A C Koole, Paola G Meregalli, M Louis Handoko, Susan Stienen, Wouter E M Kok

Nat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Digital consults in heart failure care: a randomized controlled trial.
Jelle P Man, Maarten A C Koole, Paola G Meregalli, M Louis Handoko, Susan Stienen, Wouter E M Kok

Nat Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial.
Pascal R D Clephas, Victor W Zwartkruis, Jishnu Malgie, Marco W F van Gent, Hans-Peter Brunner-La Rocca, Wouter E M Kok

Eur Heart J· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial cardiac biomarkers, pulmonary artery pressures and traditional parameters of fluid status in relation to prognosis in patients with chronic heart failure: Design and rationale of the BioMEMS study.
Youssra Allach, Mylene Barry-Loncq de Jong, Pascal R D Clephas, Marco W F van Gent, Hans-Peter Brunner-La Rocca, Wouter E M Kok

Eur J Heart Fail· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is It Useful to Repeat Blood Cultures in Endocarditis Patients? A Critical Appraisal.
Wouter Kok

Diagnostics (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors.
Esmée C de Baat, Remy Merkx, Jan M Leerink, Coen Boerhout, Heleen J H van der Pal, Judith L Kok, Wouter E M Kok

Heart· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors.
Jan M Leerink, Elizabeth A M Feijen, Esmee C de Baat, Remy Merkx, Helena J H van der Pal, Wouter E M Kok

JACC CardioOncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma.
Maria T Kuipers, Anne M Spanjaart, Francesca Bonifazi, Roberta diBlasi, Pier L Zinzani, Wouter E M Kok

Leuk Lymphoma· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial commentary: Heart failure incidence and etiologies at young adult age.
Wouter Kok

Trends Cardiovasc Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital consults to optimize guideline-directed therapy: design of a pragmatic multicenter randomized controlled trial.
Jelle P Man, Marcel G W Dijkgraaf, M Louis Handoko, Frederik J de Lange, Michiel M Winter, Wouter E M Kok

ESC Heart Fail· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unravelling the gut hypothesis of heart failure with gut microbiota-derived metabolites.
Wouter E Kok

Eur J Heart Fail· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial.
Arno A van de Bovenkamp, Kiki T J Geurkink, Frank T P Oosterveer, Frances S de Man, Wouter E M Kok

ESC Heart Fail· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extensive Cardiac Function Analyses Using Contemporary Echocardiography in Childhood Cancer Survivors: A DCCSS LATER Study.
Remy Merkx, Jan M Leerink, E Lieke A M Feijen, Esmée C de Baat, Louise Bellersen, Judith L Kok, Wouter E M Kok

JACC CardioOncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Positive inotropic agents for heart failure treatment: new avenues and questions].
Wouter E Kok

Ned Tijdschr Geneeskd· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality Screening For (Peri)Myocarditis In Newly Diagnosed Idiopathic Inflammatory Myopathies: A Cross-Sectional Study.
Johan Lim, Hannah A W Walter, Rianne A C M de Bruin-Bon, Myrthe C Jarings, R Nils Planken, Wouter E M Kok

J Neuromuscul Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Matthew J Ehrhardt, Jan M Leerink, Renée L Mulder, Annelies Mavinkurve-Groothuis, Wouter Kok

Lancet Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac function in childhood cancer survivors treated with vincristine: Echocardiographic results from the DCCSS LATER 2 CARD study.
Remy Merkx, E Lieke A M Feijen, Jan M Leerink, Esmée C de Baat, Louise Bellersen, Wouter E M Kok

Int J Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic review.
Esmée C de Baat, Elizabeth A M Feijen, Jorrit B van Niekerk, Annelies M C Mavinkurve-Groothuis, Livia Kapusta, Wouter E M Kok

Pediatr Blood Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Candidate Plasma Biomarkers to Detect Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.
Jan M Leerink, Elizabeth A M Feijen, Perry D Moerland, Esmee C de Baat, Remy Merkx, Wouter E M Kok

J Am Heart Assoc· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Carbon monoxide intoxication in a shisha lounge employee, a possible cause of cardiomyopathy].
Hatice Gülçiçek, Konstantin Prekpalaj, Bas van der Lienden, Fons Windhausen, Wouter E M Kok

Ned Tijdschr Geneeskd· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Angiotensine Receptor-Neprilysin Inhibitor combination is not the preferred medication for patients after acute myocardial infarction].
Wouter Kok

Ned Tijdschr Geneeskd· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis